Serratia infections in a general hospital: characteristics and outcomes
Autor: | Dimitra Dimopoulou, Evridiki K. Vouloumanou, Sofia Maraki, M. E. Falagas, George Samonis, E. Triantafyllou, Diamantis P. Kofteridis, M. Christofaki |
---|---|
Rok vydání: | 2011 |
Předmět: |
Adult
Male Microbiology (medical) medicine.medical_specialty medicine.drug_class Antibiotics Microbial Sensitivity Tests Drug resistance Hospitals General Serratia Serratia Infections Microbiology Endophthalmitis Internal medicine Humans Medicine Respiratory Tract Infections Serratia marcescens Aged Retrospective Studies Aged 80 and over Keratitis Cross Infection Antiinfective agent Serratia infection Greece biology business.industry General Medicine Middle Aged Antimicrobial medicine.disease biology.organism_classification Anti-Bacterial Agents Treatment Outcome Infectious Diseases business |
Zdroj: | European Journal of Clinical Microbiology & Infectious Diseases. 30:653-660 |
ISSN: | 1435-4373 0934-9723 |
DOI: | 10.1007/s10096-010-1135-4 |
Popis: | We aimed to present our experience regarding infections caused by Serratia spp. in a region with relatively high antimicrobial resistance rates. We retrospectively reviewed the databases of the microbiological laboratory of the University Hospital of Heraklion, Crete (2/2004-12/2009). A total of 77 patients [67.5% men, mean age ± standard deviation (SD) = 56.9 ± 24.5 years) were identified; 37.7% were outpatients. Sixty-five (84.4%) of the 77 included patients had a Serratia marcescens isolate; the remaining 12 patients had a non-marcescens Serratia spp. The most frequently observed infections were respiratory tract infection (32.5%) and keratitis/endophthalmitis (20.8%). Seventy-three (94.9%) patients were cured. Four deaths were observed; three of them were considered as attributed to the Serratia infection. No difference was found regarding the characteristics and outcomes between patients with Serratia marcescens and non-marcescens infections. In addition, antipseudomonal penicillins and their combinations with beta-lactamase inhibitors, as well as carbapenemes, and fluoroquinolones exhibited high antimicrobial activity against both the tested Serratia marcescens and non-marcescens isolates. Our study adds useful information regarding the characteristics and outcomes of patients with Serratia infection, as well as the susceptibilities of the respective Serratia marcescens and non-marcescens isolates, in a region with relatively high levels of antimicrobial resistance. |
Databáze: | OpenAIRE |
Externí odkaz: |